US EditionKorea Innovation Foundation Selects 2 Innovative AI/IoT Companies, C&TECH, and BeringLab for Global Technology Commercialization Support Program (North America)
The Korea Innovation Foundation selected C&TECH and BeringLab for a program offering consulting and commercialization support to trial AI and IoT technologies in North America.
- On Nov. 25, 2025, Korea Innovation Foundation selected C&TECH and BeringLab for its North America commercialization program from Daejeon, South Korea.
- The program provides comprehensive consulting to apply technologies on trial at local facilities operated by overseas companies and institutions, targeting machinery, energy, AI/IoT, and bio health for global expansion.
- Technical descriptions show that Bering Lab emphasized its strategy when Jae Yoon Kim, Co-CEO of Bering Lab, said, `This acquisition is more than expansion- it's the foundation of a broader AI roll-up strategy.'
- Selected companies will conduct on-site commercialization trials in North America arranged by the program, and C&TECH, which serves over 240 enterprise clients, may amplify demand through these pilots.
- BeringLab's acquisition-driven strategy, including Tombali and Intersphere, supports its plan to lead AI-driven consolidation in the language-services industry, while C&TECH expands into facility and building management.
47 Articles
47 Articles
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program.
Coverage Details
Bias Distribution
- 74% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
